PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 03: Articles 1001-1500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Pregnancies and oral contraceptive therapy in severe (homozygons) FXII deficiency: a study in 12 patients and review of the literature.
  2. Pregnancy, lactation, oral contraceptives, long distance travel. Discussion of thromboembolism prevention. [Schwangerschaft, Stillzeit, orale Kontrazeption, Fernreisen. Beratung zur Thromboembolieprophylaxe.]
  3. Prevalence and factors associated with practice of modern contraceptive methods among currently married women in District Naushahro Feroze.
  4. Prevalence of bacterial vaginosis among intrauterine device users in Thai women attending family planning clinic, Siriraj Hospital.
  5. Prevalence of bacterial vaginosis in Thai women attending the family planning clinic, Siriraj Hospital.
  6. Progestogens in combined oral contraceptives for contraception.
  7. Progress towards hormonal male contraception.
  8. Project takes a shot at contraceptive access.
  9. Proliferation kinetics in adenomyosis during the menstrual cycle and during oral contraceptive use. [Proliferación cinética en adenomiosis durante el ciclo menstrual y durante el uso de anticonceptivos orales.]
  10. Provision of emergency contraception to adolescents. Position paper of the Society for Adolescent Medicine.
  11. Pulmonary embolism associated with combined oral contraceptives: reporting incidences and potential risk factors for a fatal outcome.
  12. The quality of qualitative research in family planning and reproductive health care.
  13. Quick Start, an innovative approach to the combination oral contraceptive pill in adolescents. Is it time to make the switch?
  14. The range of qualitative research methods in family planning and reproductive health care.
  15. Recruitment strategies. Pharmacists' participation in an evaluation project to dispense emergency contraception.
  16. Reduction of materno-fetal transmission of HIV by improved delivery techniques combined with nevirapine treatment in women attending two family planning clinics in Yaounde, Cameroon [letter] [Réduction de la transmission materno-fotale du VIH par l'amélioration des techniques d'accouchement en combinaison avec le traitement à la névirapine chez des femmes fréquentant deux cliniques de planning familial à Yaoundé au Cameroun.]
  17. Repositioning family planning: an Advance Africa project strategy.
  18. Reproductive morbidity among contraceptive users: need for quality services.
  19. Research on contraceptives [letter]
  20. Resistance against contraception or medical contraceptive methods: a qualitative study on women and men in Istanbul.
  21. The resistance to contraceptive use in young Italian women.
  22. Rethinking contraception in Africa in the Era of HIV / AIDS [editorial]
  23. Risk and benefits of using third generation contraceptives.
  24. Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence.
  25. The role of combined oral contraceptives in the management of acne and seborrhea.
  26. The role of genetics in the risk of thromboembolism: prothrombin 20210A and oral contraceptive therapy.
  27. Scripts, close relationships, and symbolic meanings of contraceptives.
  28. The search for new and better contraceptive methods.
  29. Self-esteem, stress and self-rated health in family planning clinic patients.
  30. Should under-16s have contraceptive implants?
  31. Socioeconomic and cultural determinants on acceptance of permanent methods of contraception.
  32. SOGC clinical practice guidelines: Canadian contraception consensus.
  33. SOGC clinical practice guidelines: Canadian contraception consensus. No. 143 - Part 3 of 3, April 2004.
  34. SOGC clinical practice guidelines: Canadian contraception consensus. No. 143 - Part I of 3, February 2004.
  35. Spray-on birth control: new application eyed.
  36. Status of reproductive health and family planning in the Graueri landscape in eastern Democratic Republic of the Congo.
  37. Steroid hormones for contraception in men.
  38. Stop efforts to gag Title X family planning providers and override the federal Hyde amendment. Oppose the sweeping Abortion 'Non-Discrimination' Act (ANDA)
  39. Use of family planning services in the transition to community clinics in Abhoynagar: 1998-2002.
  40. Use of oral contraceptives and hormone replacement therapy in the WHO MONICA project.
  41. Using semi covert research to evaluate an emergency hormonal contraception service.
  42. Using the birth spacing perspective to launch family planning services in IDP sites: Advance Africa's experiences in Democratic Republic of the Congo and Angola.
  43. Vitreous haemorrhage in a 19-year-old Japanese woman using an oral contraceptive.
  44. Vocal pitch levels during connected speech associated with oral contraceptive use.
  45. Waiting for Plan B -- the FDA and nonprescription use of emergency contraception.
  46. Washington Watch: Contraceptive coverage is growing, data show.
  47. What is next for over-the-counter access to emergency contraception?
  48. Which contraceptives do we use? Current trends. [Qué anticonceptivos usamos? Tendencias actuales.]
  49. Who is being served least by family planning providers? A study of modern contraceptive use in Ghana, Tanzania and Zimbabwe.
  50. WHO updates medical eligibility criteria for contraceptives.
  51. Will emergency contraception increase sexually transmitted infections? [letter]
  52. Women say yes to direct access to contraception.
  53. You can help women achieve success with extended regimen contraception.
  54. Young Latinas recall contraceptive use before and after pregnancy: a focus group study.
  55. New contraceptive choices across reproductive life.
  56. Bayesian spatial analysis of demographic survey data: an application to contraceptive use at first sexual intercourse.
  57. Patterns of contraceptive use within teenagers' first sexual relationships.
  58. Services for men at publicly funded family planning agencies, 1998-1999.
  59. Family planning providers' perspectives on dual protection.
  60. Contraception: from accessibility to efficiency.
  61. Opportunistic screening for chlamydia at a community based contraceptive service for young people.
  62. Labeling change: new warning proposed for nonoxynol-9 contraceptive drugs. Spermicide labeling to spell out ineffectiveness against HIV, STDs.
  63. The levonorgestrel two-rod implant for long-acting contraception: 10 years of clinical experience.
  64. Local side effects observed among long-term users of Norplant contraceptive implants.
  65. Longitudinal changes in bone density in relation to oral contraceptive use.
  66. Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome.
  67. Low-dose oral contraceptive effects on thromboelastogram criteria and relationship to hypercoagulability.
  68. The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone.
  69. A 12-month evaluation of the CMA-containing oral contraceptive Belara: efficacy, tolerability and anti-androgenic properties.
  70. A 13-month multicenter clinical experience of a low-dose monophasic oral contraceptive containing 20 micrograms ethinylestradiol and 75 micrograms gestodene in Latin American women. [Experiencia clínica multicéntrica de 13-meses de un anticonceptivo oral monofásico de dosis baja con contenido de 20 microgramos de etinilestradiol y 75 microgramos de gestodeno en mujeres latinoamericanas.]
  71. The acceptability of combined oral hormonal contraceptives in Shanghai, People's Republic of China.
  72. Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study.
  73. Actual use study of emergency contraceptive pills provided in a simulated over-the-counter manner.
  74. Adolescent dual use of condoms and hormonal contraception. Trends and correlates 1991-2001.
  75. Adolescents' contraceptive use and pregnancy history: Is there a pattern?
  76. Advance supply of emergency contraception: effect on use and usual contraception -- a randomized trial.
  77. Amenorrhea associated with contraception -- an international study on acceptability.
  78. Application of simple fertility awareness -- based methods of family planning to breastfeeding women.
  79. Appropriate methods for analyzing the effect of method choice on contraceptive discontinuation.
  80. An assessment of the quality of information available on the internet about the IUD and the potential impact on contraceptive choices.
  81. Associations of mass media exposure with family planning attitudes and practices in Uganda.
  82. Awareness, prior use, and intent to use emergency contraception among Montana women at the time of pregnancy testing.
  83. Barrier contraceptive method acceptability and choice are not reliable indicators of use.
  84. Barriers to the involvement of clients in family planning service development: lessons learnt from experience.
  85. The benefits and risks of over-the-counter availability of levonorgestrel emergency contraception.
  86. Biphasic versus triphasic oral contraceptives for contraception.
  87. Bleeding patterns after immediate vs. conventional oral contraceptive initiation: a randomized, controlled trial.
  88. Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial.
  89. Bringing emergency contraception over the counter: experiences of nonprescription users in France, Norway, Sweden and Portugal.
  90. Cervical cancer and use of hormonal contraceptives: a systematic review.
  91. Changes in contraceptive use in Vietnam.
  92. Clinical study of the low dose oral contraceptive Novynette.
  93. A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men. [Ensayo clínico de implantes de 7-alfa-metil-19-nortestosterona para posible uso como anticonceptivo masculino de acción prolongada.]
  94. The combined contraceptive ring NuvaRing and spermicide co-medication.
  95. The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability.
  96. Combined estimates of effectiveness of mifepristone 10 mg in emergency contraception.
  97. Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial.
  98. Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen.
  99. Contraception in adolescents -- address on the occasion of the FBA 2002. [Kontrazeption bei jugendlichen. Vertrag anlässlich der FBA 2002.]
  100. Contraception use, family planning, and unprotected sex: few differences among HIV-infected and uninfected postpartum women in four US states.
  101. Contraceptive coverage: Is it headed your way?
  102. Contraceptive effectiveness of a polyurethane condom and a latex condom: a randomized controlled trial.
  103. Contraceptive efficacy of a depot progestin and androgen combination in men.
  104. Contraceptive practice among married market men in Nigeria.
  105. Contraceptive practice before and after termination of pregnancy: a prospective study.
  106. Contraceptive use before and after marriage in Shanghai.
  107. Contraceptive use in a changing service environment: evidence from Indonesia during the economic crisis.
  108. Cross-border procurement of contraception: estimates from a postpartum survey in El Paso, Texas. [Compra de anticonceptivos tras la frontera: estimaciones de una encuesta postparto en El Paso, Texas.]
  109. Curcumin: a potential vaginal contraceptive.
  110. Cycle control, tolerability, and satisfaction among women switching from 30-35 micrograms ethinyl estradiol-containing oral contraceptives to the triphasic norgestimate/25 micrograms ethinyl estradiol-containing oral contraceptive Ortho Tri-Cyclen LO.
  111. Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety.
  112. Determinants of contraceptive method among young women at risk for unintended pregnancy and sexually transmitted infections.
  113. Determinants of contraceptive method choice in rural Tanzania between 1991 and 1999.
  114. Development of methods of male contraception: impact of the World Health Organization Task Force.
  115. Diabetics present contraceptive dilemmas.
  116. Differences in the use of combined oral contraceptives amongst women with and without acne.
  117. Distribution of human papillomavirus in a family planning population in Nairobi, Kenya.
  118. Do oral contraceptives improve vocal quality? Limited trial on low-dose formulations.
  119. Dual contraceptive method use for pregnancy and disease prevention among HIV-infected and HIV-uninfected women.
  120. Economic analysis of contraceptives for women.
  121. Economics of reducing menstruation with trimonthly-cycle oral contraceptive therapy: comparison with standard-cycle regimens.
  122. Ectopic pregnancies following emergency levonorgestrel contraception.
  123. Effect of a low-dose oral contraceptive containing 20 micrograms ethinylestradiol and 150 micrograms desogestrel on dysmenorrhea.
  124. Effect of an oral contraceptive containing ethinyl estradiol and drospirenone on premenstrual symptomatology and health-related quality of life.
  125. Effect of four different oral contraceptives on various sex hormones and serum-binding globulins.
  126. Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters.
  127. Effect of Implanon and Norplant subdermal contraceptive implants on serum lipids -- a randomized comparative study.
  128. Effect of oral contraceptives and intrauterine devices on midcycle myometrial contractions.
  129. The effect of structural characteristics on family planning program performance in Cote d'Ivoire and Nigeria. [Effet des caractéristiques structurelles sur les performances du programme de planning familial en Côte d'Ivoire et au Nigeria.]
  130. Effect of temperature and pH on contraceptive gel viscosity.
  131. Effectiveness of the Yuzpe regimen of emergency contraception by cycle day of intercourse: implications for mechanism of action.
  132. Effects of a low-dose and ultra-low-dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study.
  133. Effects of a phasic oral contraceptive containing desogestrel on facial seborrhea and acne.
  134. Effects of oral contraceptive use on body mass index and blood pressure among female villagers in north-east Thailand.
  135. The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study.
  136. Efficacy of second versus third generation oral contraceptives in the treatment of hirsutism.
  137. Efficacy, safety and cycle control of five oral contraceptive regimens containing norgestimate and ethinyl estradiol.
  138. Emergency contraception -- clinical and ethical aspects. [Anticoncepción de emergencia: aspectos clínicos y éticos.]
  139. Emergency contraception : from accessibility to counseling. [Contraception d'urgence : de l'accessibilité à la consultation.]
  140. Emergency contraception pills (ECPs): current trends in United States college health centers.
  141. Emergency contraception: lessons learned from the UK. [Contraception d'urgence : leçons du Royaume-Uni.]
  142. Emergency contraception: pharmacy access in Albuquerque, New Mexico.
  143. Enhancing resident training in abortion and contraception through hospital-community partnership.
  144. Enlarged ovarian follicles in users of a levonorgestrel-releasing intrauterine system and contraceptive implant. [Inflamación de los folículos ováricos en usuarias de un sistema intrauterino de liberación de levonorgestrel y de un implante anticonceptivo.]
  145. Estimating optimal expenditures on family planning in developing economics.
  146. Estimating the effectiveness of emergency contraceptive pills.
  147. Estimation of births averted due to breast-feeding and increases in levels of contraception needed to substitute for breast-feeding. [Estimation des naissances évitées en raison de l'allaitement et augmentation des taux de contraception nécessaires pour se substituer à l'allaitement; [Estimación de nacimientos impedidos debido a la lactancia materna y aumentos en los niveles de anticoncepción necesarios para sustituirla.]
  148. Evaluation of an emergency contraception advance provision service.
  149. Examination of extended hormonal contraception to reduce bleeding.
  150. Expanded clinical trial of emergency contraception with 10 mg mifepristone.
  151. Expanding access to emergency contraception: the case of Brazil and Colombia. [Ampliación del acceso a la anticoncepción de emergencia: experiencia en Brasil y Colombia.]
  152. Extending the time limit for starting the Yuzpe regimen of emergency contraception to 120 hours.
  153. Factors associated with oral contraceptive discontinuation in rural Bangladesh.
  154. Factors influencing the choice to use modern natural family planning.
  155. Factors influencing young Malians' reluctance to use hormonal contraceptives. [Les facteurs qui influencent le refus des jeunes maliens à utiliser les contraceptifs hormonaux.]
  156. Failed contraception in a rural South African population.
  157. Feasibility study of the use of daily electronic mail reminder to improve oral contraceptive compliance.
  158. Female-condom use in a gender-specific family planning clinic trial.
  159. FFPRHC guidance (July 2003). Contraceptive choices for women with inflammatory bowel disease.
  160. FFPRHC guidance (October 2003). First prescription of combined oral contraception.
  161. Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception.
  162. Folic acid and oral contraceptives: Will women see a combined product? Concept: one pill to prevent unintended pregnancy, birth defects.
  163. Hormonal content and potency of oral contraceptives and breast cancer risk among young women.
  164. Hormonal contraception can suppress natural antimicrobial gene transcription in human endometrium.
  165. Hormonal contraception during lactation: systematic review of randomized controlled trials.
  166. Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda.
  167. Hormonal male contraception -- lessons from the East when the Western market fails [editorial]
  168. Human papillomavirus infection and use of oral contraceptives.
  169. Impact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deterioration.
  170. Individual and community effects of women's education and autonomy on contraceptive use in India.
  171. Influence of hormonal contraceptives on the immune cells and thickness of human vaginal epithelium.
  172. Influence of smoking and oral contraceptive on bone mineral density and bone remodeling in young women: a 2-year study.
  173. Informed choice -- the timing of postpartum contraceptive initiation.
  174. Initiating contraception in sexually transmitted disease clinic setting: a randomized trial.
  175. An innovative approach to the assessment of laypersons' knowledge of contraceptive methods, followed by an educational intervention.
  176. Integration of cervical screening in family planning clinics.
  177. Male involvement in family planning in rural Vietnam: an application of the Transtheoretical Model.
  178. Married men's opinions and involvement regarding family planning in rural areas.
  179. Mechanisms of action of mifepristone when used for emergency contraception.
  180. Meeting the reproductive health care needs of adolescents: California's Family Planning Access, Care, and Treatment Program.

     

  181. Meta-analyses of randomized trials comparing different doses of mifepristone in emergency contraception.
  182. Metoclopramide pretreatment attenuates emergency contraceptive-associated nausea.
  183. Mifepristone for luteal phase contraception.
  184. Modifying the Yuzpe regimen of emergency contraception: a multicenter randomized controlled trial.
  185. Mortality in relation to oral contraceptive use and cigarette smoking.
  186. A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men.
  187. A multicenter, randomized study of an extended cycle oral contraceptive.
  188. The need for family planning and safe abortion services among women sex workers seeking STI care in Cambodia.
  189. New contraceptive methods.
  190. Nonlatex vs. latex male condoms for contraception: a systematic review of randomized controlled trials.
  191. Obstacles to modern contraceptive use among married women in southern urban Maldives.
  192. Oral contraceptives improve lung mechanics.
  193. Oral contraceptives use and the risk of myocardial infarction: a meta-analysis.
  194. Oral contraceptives, tubal sterilization, and functional ovarian cyst risk.
  195. Oral contraceptives: a risk factor for uncontrolled blood pressure among hypertensive women. [Anticonceptivos orales: un factor de riesgo para la presión sanguínea no controlada entre mujeres hipertensas.]
  196. Ovarian function after oral contraception in infertile patients.
  197. Patient satisfaction and the impact of written material about postpartum contraceptive decisions.
  198. Patrilineal family values, family planning and variation in stature among Taiwanese six-year-olds.
  199. Patterns and predictors of female condom use among ethnically diverse women attending family planning clinics.
  200. Pharmacists' knowledge and the difficulty of obtaining emergency contraception.
  201. Pharmacokinetic differences between Caucasian and Japanese subjects after single and multiple doses of a potential combined oral contraceptive (Org 30659 and EE)
  202. Postcoital contraception in Turkey.
  203. Potential bias due to excluding oral contraceptive users when estimating menstrual cycle characteristics.
  204. Progress in contraception: new technology.
  205. Provider resistance to advance provision of oral contraceptives in Africa.
  206. Providing emergency contraceptive pills "behind-the-counter": opinions among Minnesota healthcare providers.
  207. The quality of family planning programs: concepts, measurements, interventions, and effects.
  208. Randomised controlled trial assessing the acceptability of GyneFix versus Gyne-T380S for emergency contraception.
  209. A randomized controlled trial of second- versus third-generation oral contraceptives in the treatment of acne vulgaris.
  210. A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism.
  211. Report from the Faculty of Family Planning and Reproductive Health Care AGM, May 2003. Organon Laboratories Award -- Oral Presentation Award. Medical termination of pregnancy in the late first trimester.
  212. Research eyes options in emergency contraception.
  213. Response of serum inhibin B and pro-alpha C levels to gonadotrophic stimulation in normal men before and after steroidal contraceptive treatment.
  214. Sexual partners and use of emergency contraception.
  215. Short and long-term impact of adolescent pregnancy on postpartum contraceptive use: implications for prevention of repeat pregnancy.
  216. A short-term evaluation of semen and accessory sex gland function in phase III trial subjects receiving intravasal contraceptive RISUG.
  217. Should family planning clinics provide clinical services for sexually transmitted infections? A case study from Cote d'Ivoire. [Est-ce que les cliniques de planning familial doivent fournir des services cliniques pour les maladies sexuellement transmissibles? Etude de cas de la Côte d'Ivoire.]
  218. A single dose of mifepristone (200 mg) in the immediate preovulatory phase offers contraceptive potential without cycle disruption.
  219. Sponge versus diaphragm for contraception: a Cochrane review.
  220. Supplying emergency contraception via community pharmacies in the UK: reflections on the experiences of users and providers.
  221. Surfing on the morning after: analysis of an emergency contraception website.
  222. Thermoreversible gel formulation containing sodium lauryl sulfate as a potential contraceptive device.
  223. Training and supporting pharmacists to supply progestogen-only emergency contraception.
  224. Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol. Effects on the lipid profile.
  225. Transvaginal ultrasonography in women receiving emergency contraception.
  226. Trends and determinants of contraceptive method choice in Kenya.
  227. Understanding risk: a randomized controlled trial of communicating contraceptive effectiveness.
  228. Use of prostate-specific antigen (PSA) to measure semen exposure resulting from male condom failures: implications for contraceptive efficacy and the prevention of sexually transmitted disease.
  229. Vitamin D receptor gene polymorphism and bone metabolism during low-dose oral contraceptive use in young women.
  230. Weight variation in a cohort of women using copper IUD for contraception. [Variación de peso en una cohorte de mujeres que usan dispositivos intrauterinos de cobre como método anticonceptivo.]
  231. Women's preferences for vaginal antimicrobial contraceptives. V: Attitudes of Brazilian women to the insertion of vaginal products. [Preferencias de las mujeres por los anticonceptivos vaginales antimicrobianos. Versus: Actitudes de las mujeres brasileñas respecto de la inserción de productos vaginales.]
  232. You can close the gap on unplanned pregnancies. Study says two-thirds were using contraception.
  233. Attitudes of family planning workers towards providing contraceptive services for unmarried young adults in eight centres in China.
  234. Situation analysis of emergency contraceptive use among young people in Thailand.
  235. Contraceptive behaviours of adolescents in Asia: issues and challenges.
  236. Adolescence and safety of contraceptives.
  237. Russians feel abortion's complications. Used as birth control in Soviet times, practice has led to widespread infertility.
  238. Adding family planning to PMTCT sites increases the benefits of PMTCT.
  239. Donor support for contraceptives and condoms for STI / HIV prevention, 2001.
  240. World contraceptive use, 2003. [Wallchart]
  241. Fertility, contraception and population policies.
  242. Contraception catches on in Russia.
  243. Contraception and sexual behaviour. Pill still tops the bill.
  244. Male participation in contraceptive use. [Participaçao masculina no uso de métodos contraceptivos.]
  245. Acceptability of emergency contraception in Brazil, Chile, and Mexico. 2 - Facilitating factors versus obstacles. [Grado de aceptación de los anticonceptivos de emergencia en Brasil, Chile y México. 2 - Factores que la favorecen y que la obstaculizan.]
  246. The impact of AIDS on birth control.
  247. Tajikistan: family-planning initiative meets with mixed response.
  248. Prospective study of the contraceptive effectiveness of the low copper load intrauterine device, Nova T. [Estudio prospectivo de la eficacia anticonceptiva del dispositivo intrauterino de baja carga de cobre, Nova T.]
  249. Acceptability of emergency contraception in Brazil, Chile, and Mexico. 1. Perceptions of emergency oral contraceptives. [Aceptabilidad de la anticoncepción de emergencia en Brasil, Chile y México: percepción sobre los anticonceptivos orales de emergencia.]
  250. Pharmacist training improves family planning services.
  251. The difference between emergency contraception and early abortion options (RU 486)
  252. Dominican Republic: responsive training and learning. Training improves family planning and reproductive health services at Bayaguana Hospital.
  253. Recent fertility and family planning trends in Cambodia.
  254. Unmet need for family planning: recent trends and their implications for programs. [Besoin de planning familial non satisfait : les tendances récentes et leurs implications pour les programmes.]
  255. Access to contraception vital to fight poverty, UN report says.
  256. U.S. could approve easier access to emergency contraception.
  257. Werner Fornos, Family Planning Association of Kenya named 2003 U.N. Population Award winners.
  258. Improved care increases contraceptive use.
  259. Evidence-based development of health and family planning programs in Bangladesh and Ghana.
  260. Family planning and PMTCT services: examining interrelationships, strengthening linkages.
  261. Ghana and Guatemala contraceptive choice. Clients and providers need better support and guidance on IUDs. [Elección de anticonceptivos en Ghana y Guatemala. Clientes y prestadores necesitan más apoyo y orientación sobre los DIU.]
  262. Postabortion family planning operations research study in Perm, Russia.
  263. Country analysis of family planning and HIV / AIDS: Zambia.
  264. The policy environment score. Measuring the degree to which the policy environment in Nigeria supports effective policies and programs for family planning, adolescent reproductive health and HIV / AIDS / STI. 2002.
  265. Country analysis of family planning and HIV / AIDS: Kenya.
  266. Conakry Forum on Promotion of Family Planning through Advocacy and Legislative Reform. A milestone in the FP / RH policy environment in Francophone Africa.
  267. What works: a policy and program guide to the evidence on family planning, safe motherhood, and STI / HIV / AIDS interventions. Module 1. Safe motherhood.
  268. Ensuring contraceptive supply security.
  269. Albany puts contraceptives center stage.
  270. Emergency birth control: access issues. [Contrôle des naissances "d'urgence" : problèmes d'accès.]
  271. Resisting birth control, the Philippines grows crowded. [En résistant contre le contrôle des naissances, les Philippines sont devenues surpeuplées.]
  272. Family Planning and Reproductive Health Survey 2003. End-of-project survey of selected pilot and control districts in Malawi.
  273. Birth control game up for award.
  274. What works? What fails? Findings from the Navrongo Community Health and Family Planning Project. A new beginning.
  275. Defining the components of "performance" in family planning / reproductive health for conceptual clarity and sounder measurement.
  276. Tajikistan: focus on family planning.
  277. Iran: focus on family planning.
  278. Ethiopia: call for better family planning to stop food aid dependency. [Ethiopie : Appel en vue d'une meilleure planification familiale afin de freiner la dépendance vis-à-vis de l'aide alimentaire.]
  279. Honduras: Introducing the Standard Days Method into a multi-sector family planning program. [Honduras: introducción del Método de días fijos en un programa multisectorial de planificación familiar.]
  280. Peru: Introducing the Standard Days Method into the national family planning program. [Perú: introducción del Método de días fijos en el programa nacional de planificación familiar.]
  281. The Standard Days Method: a new effective method of family planning. [El Método de días fijos: un nuevo método eficaz de planificación familiar.]
  282. Hormonal contraceptives may increase HIV risk and disease progression.
  283. Chlamydia trachomatis infection in users of two family planning clinics. [Infección por Chlamydia trachomatis en usuarias de dos clínicas de planificación familiar.]
  284. Unwanted adolescent pregnancy and post-partum utilization of contraceptive methods. [Embarazo no deseado en adolescentes, y utilización de métodos anticonceptivos posparto.]
  285. Sex partners' knowledge and attitudes towards family planning in the Peruvian rainforest. [Conocimientos y actitudes de la pareja hacia la práctica de la planificación familiar en la Selva del Perú.]
  286. Fertility pattern and family planning practises in a rural area in Dakshina Kannada.
  287. Pills that promise more than just birth control: side benefits range from clearer skin to weight loss.
  288. Relative risk of cervical cancer rises with duration of oral contraceptive use.
  289. Contraceptive use among Chinese couples changes over life of relationship.
  290. Three differing emergency contraceptive regimens are equally effective.
  291. Substantial proportions of contraceptive clinic clients would try methods that can cause amenorrhea.
  292. From home to clinic and from family planning to family health: client and community responses to health sector reforms in Bangladesh.
  293. Knowledge and perception of emergency contraception among female Nigerian undergraduates.
  294. The link between quality of care and contraceptive use.
  295. Beyond the magic bullet: introduction of emergency contraceptive pills in India.
  296. Promoting abstinence, condom use and the emergency contraception option among sexually active youth in Jamaica. An integrated message campaign.
  297. Manipulation or helpful information? Critics accuse family planning groups of pushing Western views of birth control, smaller families on developing nations. [Manipulation ou information secourable? Les critiques accusent les groupes de planning familial d'imposer les conceptions occidentales en matière de contrôle des naissances et de famille réduite aux pays en développement.]
  298. Knowledge and attitudes about emergency contraception in university students.
  299. Changes over time in college student's family planning knowledge, preference, and behavior and implications for contraceptive education and prevention of sexually transmitted infections - 1.
  300. FDA approves Ovcon 35 as the first chewable oral contraceptive tablet for women.
  301. ACOG: Investigative contraceptive device Implanon shows 100 percent efficacy in study.
  302. Family planning at each and every door.
  303. Contraceptive security index 2003: a tool for priority setting and planning.
  304. Promoting the intrauterine device for long-term contraception.
  305. Assessment of voluntary counseling and testing centers in Kenya. Potential demand, acceptability, readiness, and feasibility of integrating family planning services into VCT.
  306. The effects of education and family planning programs on fertility in Indonesia.
  307. Association of mass media exposure on family planning attitudes and practices in Uganda.
  308. Comparative analysis of program effort for family planning, maternal health, and HIV / AIDS, 30 developing countries.
  309. Fact sheet on youth: pregnancy and contraception.
  310. MGP Technical Conference for Luzon. Theme: Improving Access to Family Planning Services. Highlights of proceedings, March 3-4, 2003, EDSA Shangri-La Hotel, Mandaluyong City.
  311. Standard days method: a natural family planning option for couples. A guide for local government units.
  312. No-scalpel vasectomy: expanding options for male involvement in family planning. A guide for local government units.
  313. Qualitative factors determining poor utilization of family planning services in Angola: results of the strategic mapping exercise.
  314. Strategic mapping of the National Family Planning Program in Benin. [Plan stratégique du programme de planification familiale au Bénin.]
  315. The family planning language of ordinary folk.
  316. Imageries of family planning users.
  317. Profile of the traditional family planning method user.
  318. Profile of the modern female family planning method user.
  319. What does family planning mean to Filipinos?
  320. Situation analysis of the knowledge, attitudes and behavior of stakeholders and key target groups regarding the family planning program in the Philippines.
  321. Social Acceptance Project assessment of the 1997 DOH Family Planning Clinical Standards Manual.
  322. Frequently asked questions about USAID's family planning and reproductive health services.
  323. Family planning timeline. USAID Family Planning and Reproductive Health Program. A history of achievement.
  324. From beads to birth spacing: a new approach to natural family planning.
  325. Fertile grounds for family planning.
  326. Macro-level operational barriers to family planning services in Ethiopia: taxation and importation of contraceptives and the role of NGOs.
  327. Improving quality of care for family planning services in Uganda.
  328. The impact of quality of care on contraceptive use: evidence from longitudinal data from rural Bangladesh.
  329. Expanding contraceptive choice: integrating injectables into NGO family planning services. A guide for NGOs.
  330. Senegal Maternal Health / Family Planning Project: mid-term evaluation report, November 2003. [Projet Santé Maternelle/Planning Familial au Sénégal : rapport d'évaluation mi-semestriel, novembre 2003.]
  331. Final assessment: long-term and permanent contraception (LTPC) and postabortion care (PAC) programs, 1999-2003, Malawi.
  332. Assessment of the Contraceptive Technology Research Project at Family Health International, 1995-2005. Executive summary.
  333. Assessment of the Contraceptive Technology Research Project at Family Health International, 1995-2005.
  334. Population assistance and family planning programs: issues for Congress. Updated February 13, 2003. [Programas de asistencia a la población y de planificación familiar: temas para el Congreso. Actualización al 13 de febrero de 2003.]
  335. Introducing DMPA injectable contraceptives to private medical practitioners in urban Gujarat.
  336. Increasing male involvement in family planning through non-scalpel vasectomy.
  337. New approaches to integrating STIs, HIV / AIDS, family planning and reproductive health in Bazega, Burkina Faso.
  338. Testing a model for the delivery of emergency obstetric care and family planning services in the Bolivian public health system.
  339. Africa's family-planning funding drought.
  340. Nigeria (Bauchi, Enugu, Oyo) Family Planning and Reproductive Health Survey 2002.
  341. Combined hormonal contraceptives: effects on body weight.
  342. Combined oral contraceptives and migraine.
  343. Contraceptive sponge vs the diaphragm: efficacy and discontinuation rates.
  344. Emergency contraception: an update.
  345. Contraception during breastfeeding.
  346. Myths about oral contraceptives.
  347. The potential market for expanded private-sector family planning in the Philippines.
  348. Pakistan: increasing access to hormonal family planning methods through social marketing.
  349. Madagascar: fighting HIV / AIDS and improving access to modern family planning through the private sector. [Madagascar : lutter contre le SIDA/VIH et améliorer l'accès au planning familial moderne par l'intermédiaire du secteur privé.]
  350. Jordan: an integrated approach to increasing use of modern family planning methods.
  351. Ghana: working through the private sector to improve access to family planning and combat HIV / AIDS.
  352. Bangladesh: strengthening contraceptive security.
  353. Bangladesh. Contraceptive market segmentation analysis. Final report.
  354. USAID phaseout of free contraceptives raises more problems for Philippines' poor.
  355. Family planning plus: HIV / AIDS basics for non-governmental organizations (NGOs) and family planning program managers. Integrating reproductive health and HIV / AIDS for non-governmental organizations, faith-based organizations and community-based organizations. Vol. I.
  356. Repeated use of emergency contraception: the facts. Policy statement.
  357. Emergency contraception and medical abortion.
  358. Improving access to emergency contraception.
  359. How do emergency contraceptive pills work to prevent pregnancy?
  360. Emergency contraceptive pills: medical and service delivery guidelines. 2nd ed.
  361. China's family planning program is just the beginning.
  362. Contraceptive knowledge, practices and utilization of services in the rural areas of India (an ICMR Task Force Study)
  363. Knowledge, attitude and practice of family planning amongst women with unplanned pregnancy in Calabar - Nigeria.
  364. Hormonal contraceptive counseling for adolescents. Reproductive Health Initiative model curriculum, 2nd ed. Module 2: Psychosocial factors.
  365. Teenagers turning to contraceptives.
  366. Emergency contraception use increases when pills are provided in advance.
  367. Some women with genetic susceptibility to breast cancer face elevated risk from oral contraceptive use.
  368. Availability of emergency contraception through student health centers is growing, but gaps remain.
  369. Contraceptive ring found safe, effective: most users would recommend it.
  370. The standard days method of family planning: a response to Cairo.
  371. The impact of household delivery of family planning services on women's status in Bangladesh.
  372. Facility-level reproductive health interventions and contraception use in Uganda.
  373. Bangladeshi women weigh a variety of factors when choosing a contraceptive.
  374. Can women's childbearing and contraceptive intentions predict contraceptive demand? Findings from a longitudinal study in central India.
  375. Relationships between contraception and abortion: a review of the evidence. [Rapport entre contraception et avortement : examen des faits; [Relaciones entre anticoncepción y aborto: revisión de la evidencia.]
  376. Family planning and the fight against smoking and obesity.
  377. Emergency contraception: improving access.
  378. Emergency contraception: increasing public awareness.
  379. Adolescent protective behaviors: abstinence and contraceptive use. [Comportements de protection des adolescents : abstinence et utilisation du contraceptif.]
  380. Family planning and the prevention of mother-to-child transmission of HIV: technical and programmatic issues.
  381. Scaling up family planning and reproductive health programs.
  382. The Best Practices Compendium: a dynamic family planning / reproductive health resource for managers.
  383. Peru moves away from birth control.
  384. Argentine contraceptive ban "absurd".
  385. Women's knowledge and sources of information on the risks and benefits of oral contraception.
  386. Contraceptive fact sheets.
  387. Belgium to subsidise costs of contraception to teenagers.
  388. Emergency contraception. Even easier to prescribe, but users still need a holistic sexual health service [editorial]
  389. Influence of the third generation pill controversy on prescriptions for oral contraceptives among first time users: population based study.

     

  390. Thromboembolism associated with the new contraceptive Yasmin.
  391. Discontinuation of contraceptive use in Ghana.
  392. Potential role of male community-based distributors in a family-planning programme in western Uganda: results of a pilot study.
  393. The provision and use of progestogen-only contraceptives amongst antenatal and postpartum women in a rural area of the Eastern Cape.
  394. Investigating the knowledge, attitude and its relationship with the mean of using emergency contraception.
  395. Ischemic stroke risk in oral contraceptive users [letter]
  396. Knowledge, attitude, and behavior of female students concerning contraception in Athens, Greece.
  397. Lactational amenorrhea for family planning.
  398. Lactational amenorrhea for family planning.
  399. Laparoscopic treatment of peri-appendicitis caused by intrauterine contraceptive device. [Tratamento laparoscópico de periapendicite causada por dispositivo intra-uterino.]
  400. Leptin levels in patients with polycystic ovary syndrome in response to two different oral contraceptive treatments.
  401. Less estrogen in new oral contraceptive.
  402. Lessons learned from Colombia. IPPF / WHR spotlight on emergency contraception. [Lecciones aprendidas de Colombia. IPPF y WHR se centran en la anticoncepción de emergencia.]
  403. Levonorgestrel and mifepristone in emergency contraception.
  404. Levonorgestrel as an emergency contraceptive drug.
  405. The link between contraceptive prevalence and abortion.
  406. Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance.
  407. Male contraception: mechanical, hormonal and non-hormonal methods.
  408. Male contraceptive technology.
  409. 20 mcg versus > 20 mcg estrogen combined oral contraceptives for contraception.
  410. Abortion rate and contraceptive practices in immigrant and native women in Sweden.
  411. Abortion, birth control, and contraception: fertility decline in Norway.
  412. Abortion, contraceptive use, and adolescent pregnancy among first-year medical students at a major public university in Mexico City. [Aborto, uso de anticonceptivos y embarazos adolescentes en estudiantes del primer año de la escuela de medicina de una importante universidad pública de la ciudad de México.]
  413. The acceptability and use of contraception: a prospective study of Somalian women's attitude.
  414. Access to emergency contraception.
  415. Adequacy of knowledge on contraceptive methods among women of Campinas, Sao Paulo. [Adequaçao do conhecimento sobre métodos anticoncepcionais entre mulheres de Campinas, Sao Paulo.]
  416. Adolescent access to emergency contraception in A and E departments: reviewing the literature from a feminist perspective.
  417. Adolescent contraception and pregnancy from the perspective of young low-income fathers in a slum area in Rio de Janeiro. [Contracepçao e gravidez na adolescência na perspectiva de jovens pais de uma comunidade favelada do Rio de Janeiro.]
  418. Adolescent mothers' utilization of contraceptive services in South Africa.
  419. Advanced supply of emergency contraception for adolescent mothers increased utilization without reducing condom or primary contraception use. [La mise à disposition d'avance de la contraception d'urgence pour les mères adolescentes a augmenté le taux d'utilisation sans réduire l'usage du préservatif ou de la contraception primaire.]
  420. Advances in hormonal contraception. Over time, methods have become safer, more acceptable, easier to use, and more diverse.
  421. Advancing towards a male contraceptive: a novel approach from an unexpected direction.
  422. Appreciative Community Mobilization (ACM) increases contraceptive use in the Philippines.
  423. Argentina. Women take the reins on their contraception. [Argentina. Mujeres toman las riendas de su contracepción.]
  424. Assessing the performance of pharmacy agents in counseling family planning users and providing the pill in Benin: an evaluation of Intrah / PRIME and PSI training assistance to the Benin Social Marketing Program. [Evaluation des performances des employés de pharmacie en matière de counseling aux utilisateurs du planning familial et de fourniture de la pilule au Bénin : évaluation de l'assistance INTRAH/PRIME et PSI dans le domaine de la formation au Programme Béninois de Marketing Social.]
  425. Assessment of the Innovations in Family Planning Services Project. Summary report.
  426. Associations of family support, resiliency, and depression symptoms among indigent teens attending a family planning clinic.
  427. Biphasic versus monophasic oral contraceptives for contraception.
  428. Birth control consipracy beliefs, perceived discrimination, and contraception among African Americans: an exploratory study.
  429. Birth control in Russia.
  430. Blood levels of homocysteine, folate, vitamin B6 and B12 in women using oral contraceptives compared to non-users.
  431. Bone mineral density in adolescent and young adult women on injectable or oral contraception.
  432. Breast cancer and specific types of oral contraceptives: a large Norwegian cohort study.
  433. Bridewealth and birth control: low fertility in the Indonesian Archipelago, 1500 - 1900.
  434. Building emergency contraception awareness among adolescents: a toolkit for schools and community-based organizations.
  435. Carpal tunnel syndrome and oral contraceptive drugs: risk or protective factor? [letter]
  436. A case of female alcoholic who developed liver cirrhosis with small amounts of alcohol by the common use of contraceptive agent]
  437. A case/comparison study in the eastern region of Ghana on the effects of incorporating selected reproductive health services on family planning services.
  438. Catalyst consortium addresses family planning and reproductive health needs in developing countries.
  439. Changing family planning scenario in India: an overview of recent evidence.
  440. Choices in family planning: informed and voluntary decision making. Realizing rights in sexual and reproductive health services.
  441. Choosing when to menstruate: the role of extended contraception.
  442. Closing family planning gap is global priority.
  443. Combination contraceptives: effects on weight.
  444. Combination estrogen-progestin oral contraceptives.
  445. Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women.
  446. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation.
  447. The combined oral contraceptive pill in women over age forty.
  448. Combined oral contraceptives (COCs)
  449. Combined oral contraceptives and the risk of myocardial infarction.
  450. Commentary on repeat emergency contraception [letter]
  451. Commentary on repeat emergency contraception. Response to letter to the editor [letter]
  452. Communication about contraception and knowledge of oral contraceptives amongst Norwegian high school students.
  453. A comparative analysis of the modification of sexual desire of users of oral hormonal contraceptives and intrauterine contraceptive devices.
  454. Concept analysis of adolescent decision making and contraception.
  455. Consensus statement: Menstrual and contraceptive management in women with an intellectual disability.
  456. Contraception and abortion attitudes and practices of western Ukraine women.
  457. Contraception and contractions: a divergent decade following Johnson controls.
  458. Contraception before and after termination of pregnancy: can we do it better?
  459. Contraception forecast: You'll have new options.
  460. Contraception in late nineteenth- and early twentieth-century Finland.
  461. Contraception in the perimenopause.
  462. Contraception. Hormonal contraceptives.
  463. Contraceptive choices in medically ill adolescents.
  464. Contraceptive choices: new options in the U.S. market.
  465. The contraceptive conundrum.
  466. Contraceptive efficacy of bioadhesive nonoxynol-9 gel: comparison with nonoxynol-9 suppository.
  467. Contraceptive emergency. Catholic hospitals overwhelmingly refuse to provide EC.
  468. Contraceptive methods used by young women in the township of Lomé, Togo. [Utilisation des méthodes contraceptives par les jeunes femmes de Lomé (Togo)]
  469. Contraceptive patch catches on with women.
  470. Contraceptive practices among students. [Metody zapobiegania niepozadanej ciazy wsrod studentow.]
  471. Contraceptive practices of non-HIV-seropositive injecting drug users.
  472. Contraceptive self-efficacy: does it influence adolescents' contraceptive use?
  473. Contraceptive use among adolescents at public schools in Bahia. [Uso de contracepçao por adolescentes de escolas públicas na Bahia.]
  474. Contraceptive use dynamics in Egypt: an in-depth analysis.
  475. Contraceptive use is critical to stability in Bangladesh.
  476. Contraceptive use is key to reducing abortion worldwide.
  477. Controversies in adolescent contraception.
  478. The cost of contraceptive insurance coverage. [Coût de couverture de l'assurance du contraceptif.]
  479. Cost-effectiveness of emergency contraceptive pills in the public sector in the USA.
  480. Counselling in family planning.
  481. Couples' views of the effects of natural family planning on marital dynamics.
  482. Covariates of contraceptive use across the regions of India: a study of Jharkhand and Uttaranchal.
  483. Depot medroxyprogesterone acetate (DMPA) injectable contraception -- safe, effective but neglected method of family planning in Poland. [Octan medroksyprogesteronu podawany domiesniowo -- skuteczna ale rzadka forma antykoncepcji.]
  484. Developing new and improved methods of contraception.
  485. Diaphragm versus diaphragm with spermicides for contraception.
  486. Discontinuation of contraceptive use in northeast Brazil, 1986-1991. [Descontinuaçao de métodos anticoncepcionais no nordeste do Brasil, 1986-1991.]
  487. Disturbingly low levels of contraception among women living with hepatitis C.
  488. DMPA: the injectable contraceptive.
  489. Effect and control of oral contraceptive Minesse (15 mkg EE / 60 mkg Gestoden) on menstrual cycle and body weight.
  490. Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms.
  491. Effects of progestogen-only, combined estrogen/progestogen versus non-hormonal contraception on carbohydrate and lipid metabolism in women with diabetes.
  492. Effects of testosterone undecanoate as a male contraceptive candidate on rat immunological features.
  493. The efficacy of non-contraceptive uses for hormonal contraceptives.
  494. Emergency contraception and risk of ectopic pregnancy: Is there need for extra vigilance? [letter]
  495. Emergency contraception for prevention of adolescent pregnancy.
  496. Emergency contraception given via a patient group direction.
  497. Emergency contraception in France: the user profile. [Caractéristiques des utilisatrices de pilule du lendemain, en France.]
  498. Emergency contraception pills (ECPs)
  499. Emergency contraception provision catches on.
  500. Emergency contraception update.

To view other lists of the current category of articles, please visit "Category Lists Homepage"